Weil K, Hooper L, Afzal Z, Esposito M, Worthington H V, van Wijk A J, Coulthard P
School of Dentistry, University of Manchester, Oral and Maxillofacial Surgery, Higher Cambridge Street, Manchester, UK, M15 6FH.
Cochrane Database Syst Rev. 2007 Jul 18;2007(3):CD004487. doi: 10.1002/14651858.CD004487.pub2.
Paracetamol has been commonly used for the relief of postoperative pain following oral surgery. In this review we investigated the optimal dose of paracetamol and the optimal time for drug administration to provide pain relief, taking into account the side effects of different doses of the drug. This will inform dentists and their patients of the best strategy for pain relief after the surgical removal of wisdom teeth.
To assess the beneficial and harmful effects of paracetamol for pain relief after surgical removal of lower wisdom teeth, compared to placebo, at different doses and administered postoperatively.
We searched the Cochrane Oral Health Group's Trials Register; the Cochrane Pain, Palliative and Supportive Care Group's Trials Register; CENTRAL; MEDLINE; EMBASE and the Current Controlled Trials Register. Handsearching included several dental journals. We checked the bibliographies of relevant clinical trials and review articles for studies outside the handsearched journals. We wrote to authors of the identified randomised controlled trials (RCTs), to manufacturers of analgesic pharmaceuticals, we searched personal references in an attempt to identify unpublished or ongoing RCTs. No language restriction was applied. The last electronic search was conducted on 24th August 2006.
Randomised, parallel group, placebo controlled, double blind clinical trials of paracetamol for acute pain, following third molar surgery.
All trials identified were scanned independently and in duplicate by two review authors, any disagreements were resolved by discussion, or if necessary a third review author was consulted. The proportion of patients with at least 50% pain relief was calculated for both paracetamol and placebo. The number of patients experiencing adverse events, and/or the total number of adverse events reported were analysed.
Twenty-one trials met the inclusion criteria. A total of 2048 patients were initially enrolled in the trials (1148 received paracetamol, and 892 the placebo) and of these 1968 (96%) were included in the meta-analysis (1133 received paracetamol, and 835 the placebo). Paracetamol provided a statistically significant benefit when compared with placebo for pain relief and pain intensity at both 4 and 6 hours. Most studies were found to have moderate risk of bias, with poorly reported allocation concealment being the main problem. Risk ratio values for pain relief at 4 hours 2.85 (95% confidence interval (CI) 1.89 to 4.29), and at 6 hours 3.32 (95% CI 1.88 to 5.87). A statistically significant benefit was also found between up to 1000 mg and 1000 mg doses, the higher the dose giving greater benefit for each measure at both time points. There was no statistically significant difference between the number of patients who reported adverse events, overall this being 19% in the paracetamol group and 16% in the placebo group.
AUTHORS' CONCLUSIONS: Paracetamol is a safe, effective drug for the treatment of postoperative pain following the surgical removal of lower wisdom teeth.
对乙酰氨基酚常用于缓解口腔手术后的疼痛。在本综述中,我们研究了对乙酰氨基酚的最佳剂量以及给药的最佳时间,以实现疼痛缓解,同时考虑到不同剂量药物的副作用。这将为牙医及其患者提供有关拔除智齿后疼痛缓解的最佳策略。
评估与安慰剂相比,不同剂量的对乙酰氨基酚在术后给予时,对拔除下颌智齿后疼痛缓解的有益和有害影响。
我们检索了Cochrane口腔健康组试验注册库;Cochrane疼痛、姑息和支持治疗组试验注册库;Cochrane系统评价数据库;医学期刊数据库;荷兰医学文摘数据库以及当前对照试验注册库。手工检索包括几本牙科杂志。我们检查了相关临床试验和综述文章的参考文献,以查找手工检索杂志之外的研究。我们写信给已识别的随机对照试验(RCT)的作者、镇痛药物制造商,搜索个人参考文献,试图识别未发表或正在进行的RCT。未应用语言限制。最后一次电子检索于2006年8月24日进行。
对乙酰氨基酚用于第三磨牙手术后急性疼痛的随机、平行组、安慰剂对照、双盲临床试验。
所有识别出的试验均由两位综述作者独立且重复扫描,任何分歧通过讨论解决,如有必要会咨询第三位综述作者。计算对乙酰氨基酚组和安慰剂组中疼痛缓解至少50%的患者比例。分析发生不良事件的患者数量和/或报告的不良事件总数。
21项试验符合纳入标准。共有2048名患者最初纳入试验(1148名接受对乙酰氨基酚,892名接受安慰剂),其中1968名(96%)纳入荟萃分析(1133名接受对乙酰氨基酚,835名接受安慰剂)。与安慰剂相比,对乙酰氨基酚在4小时和6小时时对疼痛缓解和疼痛强度具有统计学显著益处。发现大多数研究存在中度偏倚风险,主要问题是分配隐藏报告不佳。4小时时疼痛缓解的风险比为2.85(95%置信区间(CI)1.89至4.29),6小时时为3.32(95%CI 1.88至5.87)。在高达1000毫克和1000毫克以上剂量之间也发现了统计学显著益处,在两个时间点上,剂量越高,各项指标的益处越大。报告不良事件的患者数量之间无统计学显著差异,总体上对乙酰氨基酚组为19%,安慰剂组为16%。
对乙酰氨基酚是治疗拔除下颌智齿后术后疼痛的一种安全、有效的药物。